Shows
Business News Today | 2 Min News | The Daily News Now!Insulet’s Stock Drop Hides Strong Fundamentals
Insulet’s stock has plunged over 50%, but the numbers tell a different story: revenue is growing 27% YoY after adjusting for currency, free cash flow margins have jumped 25+ points in five years, and ROIC is climbing—hinting at a resilient, improving business that might now be undervalued for long-term investors.
Support the show:Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.Report issues to feedback@thednn.ai.
View sources & latest updates:h...
2026-06-0401 minBusiness News Today | 2 Min News | The Daily News Now!Insulet vs DexCom 2026 Investment Play
DexCom and Insulet dominate the diabetes tech scene—DexCom with real-time glucose monitoring, Insulet with wearable insulin pumps. DexCom raked in $4.7B in revenue (15.6% growth) and $836M net profit, while Insulet surged 30% to $2.7B in revenue and $354M net income. Both manage debt well, but Insulet’s lower valuation and growth potential make it the smarter 2026 investment play—despite risks like competition, FDA warnings, and reliance on partnerships.
Support the show:Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:advertise@thednn.ai
This is an automated, high-level news s...
2026-06-0402 min
Mesa News Today | 2 Min News | The Daily News Now!Insulet Recalls 7M Insulin Pods
Insulet’s recalling 7 million Omnipod insulin pods due to a tiny tubing tear that can cause dangerous insulin leaks — leading to high blood sugar, hospitalizations, and diabetic ketoacidosis. Affected devices include Omnipod 5, DASH, and Eros. No deaths reported. Customers are urged to stop using affected pods immediately and get free replacements. Check your pod’s lot number on the tray or device, then verify via Insulet’s online checker. Support is available via phone or live chat.
Support the show:Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:advertise@thednn.a...
2026-05-2701 min
The Digital Health Podcast with Fexingo: Wearables, Diagnostics, and Health SoftwareThe Insulet Omnipod 5 Closed-Loop Insulin Delivery RevolutionEpisode 6 of The Digital Health Podcast zooms in on the Insulet Omnipod 5, the first tubeless automated insulin delivery system. Lucas and Luna break down how this wearable patch pump, paired with a smartphone app and continuous glucose monitor, creates a closed loop that adjusts insulin in real time. They discuss the 2022 FDA approval, the pivotal clinical trial showing a 2.1 percentage point improvement in time-in-range for type 1 diabetes patients, and how the system reduces the mental burden of constant decision-making. The hosts also explore Insulet's market positioning against Medtronic and Tandem Diabetes, the role of Dexcom G6 integration, and why...
2026-05-2310 min
Within Range: Demystifying Diabetes Tech for Healthcare ProfessionalsRADIANT Trial Results: The Impact on Type 1 Diabetes (T1D) Patients and a Glimpse into the Future of Diabetes CareWhat happens when you transition type 1 diabetes (T1D) patients from multiple daily injections (MDI) to Omnipod 5 using Abbott’s Freestyle Libre 2? That is exactly what the RADIANT Randomized Controlled Trial (RCT) investigated.
Listen to Within Range with Kate Neal, Clinical Services Manager at Insulet who is joined by Dr. Emma Wilmot - Associate Professor at University of Nottingham, consultant Diabetologist, & founder of the Diabetes Technology Network UK - to unpack the incredible results of the RADIANT trial and discuss its impact on patients and the future of diabetes care.
Recently published in The Lancet Diabetes & Endocrinology journal, ...
2026-04-2117 min
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesATTD 2026 Recap
Advances in artificial intelligence, automated insulin delivery, and sensor integration were central to discussions at the 2026 International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), where clinicians highlighted how emerging technologies may further reduce diabetes management burden while improving glycemic outcomes.In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, reviewed key highlights from the meeting, with particular emphasis on AI-driven tools and evolving closed-loop systems.A major theme was the growing role of artificial intelligence, including the concept of “digital twins”—virtual models built from patient-specific data such as glucose trends, insulin dosing...
2026-03-1932 min
Within Range: Demystifying Diabetes Tech for Healthcare ProfessionalsREPLAY: Understanding Omnipod 5: The future of Diabetes TechIn our inaugural episode, hosts Kate Neal and Cindy Pickering are joined by Dr Sufyan Hussain, consultant in diabetes, endocrinology and general medicine at Guys and St Thomas’s Hospital in London. Dr Hussain talks about his personal and professional experience with type 1 diabetes and how he has seen technology rapidly evolve over the past decade. He discusses his work as a clinician, helping others to manage diabetes with game-changing results through Omnipod® 5 and the approach to training patients on the Omnipod® 5 System in the UK. He provides practical advice to clinicians and sets expectations for patients just starting out...
2026-03-1729 min
モンティの米国株決算まとめポッドキャストInsulet 2025年決算報告：Omnipodの躍進と30%超の売上成長、そして2026年への展望今回のエピソードでは、Insulet Corporationが発表した2025年第4四半期および通期の記録的な決算結果について詳しく解説します。Insuletは第4四半期および通期で前年比31%の増収を達成し、為替変動の影響を除いたベースで10年連続となる20%以上の成長を記録しました。主なトピックとして、Omnipod 5の世界的な普及拡大、米国および欧州における新規顧客獲得数No.1の達成、そしてFDAによる新機能の承認など、2025年の重要なマイルストーンを振り返ります。また、取締役会で承認された3億5,000万ドルの自社株買いプログラムや、売上総利益率の改善といった財務健全性についても分析します。最後に、2026年に向けて同社が発表した強気なガイダンスと、持続的な成長戦略について議論します。
2026-02-1804 min
Within Range: Demystifying Diabetes Tech for Healthcare ProfessionalsClinical Data and Practical Experience: The Impact of Omnipod® 5For people living with type 1 diabetes, simplifying daily glycaemic management is essential, and Omnipod 5 is helping people do just that. In this episode of Within Range, host Kate Neal - Clinical Services Manager at Insulet, sits down with Dr Fraser Gibb - Consultant Physician and Diabetologist at Edinburgh Royal Infirmary and Honorary Clinical Reader at the University of Edinburgh, to explore how Omnipod 5’s intuitive technology makes diabetes care more accessible. They highlight how the device’s tubeless design and hybrid closed loop system transform diabetes management, improving outcomes. This episode of Wit...
2026-02-1736 min
Health Podcast ShowHow this Medical Device Company Reaches Users with PodcastsWhat if the best place to launch a healthcare podcast was a coffee table at a trade show? That's exactly what Dan Cottrell (The Podcast Guys) and Sejal Patel (Insulet) did with "Beyond the Bolus," growing it from a makeshift recording space at ADA's New Orleans conference to over 100,000 downloads in four years.
Sejal reveals how she convinced skeptical stakeholders to invest in untested audio content for HCPs, while Dan explains the strategic advantage of capturing thought leaders at conferences where they're already gathered. With medical team members present during recordings to flag compliance...
2026-01-1950 min
Within Range: Demystifying Diabetes Tech for Healthcare ProfessionalsIs 70% Time in Range really 70% Time in Range? Making Sense of CGM Accuracy and the impact on Automated Insulin DeliveryAutomated insulin delivery (AID) relies on the accuracy of the sensor behind it—so what happens when “70% time in range” doesn’t mean the same thing across different continuous glucose monitoring (CGM) systems?Recorded at EASD in Vienna, this special episode of Within Range brings together clinical, research and real-world perspectives to unpack how CGM accuracy, comparator methods (capillary vs venous) and standardisation efforts shape the numbers healthcare professionals rely on every day.Registered dietitian and diabetes educator John Pemberton uses a powerful “strict vs lenient marker” analogy to explain why identical time in rang...
2026-01-0734 min
Within Range: Demystifying Diabetes Tech for Healthcare ProfessionalsChallenging Bias: Making Diabetes Tech Accessible for EveryoneAlthough guidelines are pointing to Automated Insulin Delivery Systems as standard of care for managing type 1 diabetes, not all people are being offered AID as a therapy option. Why are some people still left behind—and what can healthcare professionals do about it?In this episode of Within Range from EASD 2025 in Vienna, host Kate Neal, Clinical Services Manager at Insulet, speaks with Dr. Alice Cheng and Dr. Hood Thabit about how unconscious bias, clinical inertia, and outdated assumptions continue to shape who gets offered diabetes technology.They discuss wh...
2025-12-0233 min
Within Range: Demystifying Diabetes Tech for Healthcare ProfessionalsThe Origin Story of Omnipod®: Celebrating 25 Years of Innovation at InsuletHow did a sketch on a napkin during a cross-country flight spark a revolution in diabetes care? Following live discussions at the European Association for the Study of Diabetes (EASD) 2025 in Vienna, Within Range host Kate Neal introduces a special conversation led by Dominic Hulton, Vice President of International Marketing at Insulet, with John Brooks, founder of Insulet and the visionary behind tubeless insulin delivery which eventually led to the development of the Omnipod 5 Automated Insulin Delivery System. John shares personal insights into the early days of Insulet, developing the first tubeless insulin delivery s...
2025-11-1409 min
Within Range: Demystifying Diabetes Tech for Healthcare ProfessionalsReal-world success stories about diabetes management thanks to automated insulin delivery (AID) and Omnipod® 5: Recorded at the American Diabetes Association (ADA) Conference 2025Following live discussions with health-care providers about their experiences with Omnipod 5 at the American Diabetes Association (ADA) Conference 2025, Within Range hosts Kate Neal and Cindy Pickering reflect on how automated insulin delivery systems provide discretion and comfort, empowering patients in their diabetes care and improving outcomes after diagnosis. We hear touching stories including one about a teenage girl finally embracing her diagnosis thanks to advancements in diabetes technology, as well as stories of children and adults improving their quality of life thanks to automated insulin delivery. Who you’ll hear...
2025-10-2125 min
The AI in Business PodcastAchieving Personalization and Compliance in Med Tech Solutions - with Faithe Toomy of InsuletToday's guest is Faithe Toomy, Director of Voice of the Customer and Insights at Insulet. Insulet is a medical device company specializing in wearable drug delivery systems for diabetes care, combining engineering, clinical research, and digital health capabilities to develop automated therapeutic solutions. Faithe joins Emerj Editorial Director Matthew DeMello to discuss how data and AI are transforming call center operations while maintaining compliance and customer trust. Faithe also shares practical strategies for training agents, leveraging conversational analytics, and implementing AI tools that enhance workflow efficiency, improve first-contact resolution, and support a more confident, human-centered customer experience. Want to...
2025-09-3022 min
Within Range: Demystifying Diabetes Tech for Healthcare ProfessionalsHow customisable glucose targets can individualize patient careHow to set multiple glucose target levels throughout the day and how to use customisation with Omnipod 5 to manage insulin sensitivity are what host Kate Neal - Clinical Services Manager at Insulet - talks to John Pemberton about on this episode of Within Range.Pemberton is a renowned Paediatric Diabetes Dietitian who works to improve patient outcomes. He’s an author of the EASD/ISPAD 2024 AID and Exercise Consensus Guidance which provide comprehensive recommendations for managing physical activity in children, adolescents and young adults with diabetes. Neal and Pemberton share insights into the...
2025-09-0224 min
Within Range: Demystifying Diabetes Tech for Healthcare ProfessionalsLet’s Talk About Diabetes Tech, Intimacy, and Type 1: The Conversations We’re Not HavingIn this special episode of Within Range, recorded live in Amsterdam at ATTD, host Cindy Pickering, Clinical Services Manager at Insulet, sits down with the team behind the podcast Typecast: Life Between the Lines to explore a topic that’s deeply personal, and too often overlooked in diabetes care: intimacy.Cindy is joined by:
Natalie Balmain – Omnipod Ambassador, activist, and host of Typecast
Amanda Epps – Diabetes Specialist Nurse and researcher on diabetes tech and intimacy
Timothy Jenkinson (aka Grace Shush) – Drag artist and diabetes advocate
Together, they bring decades of lived experience with Type...
2025-08-2641 min
Within Range: Demystifying Diabetes Tech for Healthcare ProfessionalsHow to empower patients by giving them a truly bespoke treatment planThe personalisation and ease of use of Omnipod 5, its impact on improving patients' quality of life, and the Custom Foods feature that empowers users with a personalised meal library are what host Kate Neal - Clinical Services Manager at Insulet - and Dr. Eden Miller - a Family Practitioner and Diabetologist - discuss on this episode of Within Range.Dr. Miller shares personal and poignant patient stories, bringing to light the psychological and medical barriers in accessing modern diabetes tech and how she collaborates with patients to overcome them.In this episode of Within Range...
2025-08-1229 min
Diabetes Care ConversationsSimplifying Meal Bolusing with Carb Awareness SkillsBecky Sulik, RDN, LD, CDCES, and Bethany Long, BSN, RN, CDCES, join us to discuss how automated insulin delivery systems (AID), like the Omnipod 5, are transforming diabetes management and making mealtime bolusing easier. Becky and Bethany share insights on the Omnipod 5 AID system, including user-friendly built-in features that facilitate onboarding and increase carb awareness skills in a variety of people with diabetes. The episode highlights real-world applications and personal stories that diabetes care and education specialists can utilize in practice to quickly onboard and empower their clients today. This episode was supported by Insulet. A guest featured on...
2025-08-0619 min
Diving Into DiabetesChanging the trajectory of T1D with screening and monitoringHow can early identification transform type 1 diabetes (T1D) care and what groundbreaking advances are on the horizon?Our host, Dr. Alice Cheng, explores this topic with Dr. Karen McAssey, a pediatric endocrinologist, researcher, educator, and advocate for people living with T1D at McMaster Children's Hospital in Hamilton, Ontario.Join our experts for a compelling conversation that delves into the profound impact of diabetic ketoacidosis (DKA) and unveils how early intervention can change the course of T1D. Discover why preventing DKA at diagnosis is paramount, learn about the latest consensus guidance for monitoring...
2025-07-2917 min
Diabetics Doing Things PodcastEpisode 316 - Jordy KuiperIn this episode of the Diabetes Innovators Series, Eric Benjamin, Chief
Product and Customer Experience Officer at Insulet, discusses the latest
innovations in diabetes management, particularly focusing on the
integration of the Dexcom G7 with the Omnipod 5 system. He emphasizes the
importance of usability, patient-centric design, and the company's
commitment to making diabetes management easier and more effective for
users. Eric shares insights into the future of closed-loop systems and the
cultural ethos at Insulet that drives their innovation efforts.
Chapters
00:00 Introduction to Insulet and Eric Benjamin
00:40 Integration of Dexcom G7 with Omnipod 5
02:22 Innovations in Diabetes Management
04:58 Patient-Centric Approach to...
2025-07-0800 min
Within Range: Demystifying Diabetes Tech for Healthcare ProfessionalsTailored recommendations for Automated Insulin Delivery (AID) use during exerciseIntroducing the Exercise Wheel and the Consensus Recommendations for managing Type 1 Diabetes during exercise are the focus of this conversation between host Kate Neal - Clinical Services Manager at Insulet - and Dr. Othmar Moser - a leading expert in exercise physiology and metabolism from the University of Bayreuth and the University of Graz. There is new guidance developed by European Association for the Study of Diabetes (EASD) and International Society for Pediatric and Adolescent Diabetes (ISPAD), which provide evidence-based recommendations for managing glucose levels during planned and unplanned physical activities using AID Systems l...
2025-07-0133 min
Diving Into DiabetesConnecting the care team: Optimizing insulin management for diabetes What are the most effective ways for a diabetes care team to tackle the complexities and challenges of insulin management for patients? Our host, Dr. Alice Cheng, discusses practical approaches in coordinating multidisciplinary diabetes care with Dr. Michelle Long, a Primary Care Physician based in Port Hope, Ontario, with more than 30 years in clinical practice, and Ms. Susie Jin, a Pharmacist and Certified Diabetes Educator based in Cobourg, Ontario, recognized for her national leadership in diabetes. Together, our experts explore the importance of a connected care team—including endocrinologists, general practitioners, pharmacists, and diabetes educators—in optimizing...
2025-05-2317 min
Diving Into DiabetesType 2 Diabetes: Treatment Priorities in Primary CareCurious about how primary care practitioners are managing the complexities of type 2 diabetes (T2D) in their practice?Join our host Dr. Alice Cheng as she delves into this topic with Dr. James Kim, Clinical Assistant Professor in the Department of Family Medicine at the University of Calgary, lead editor for the Primary Care section of the Canadian Journal of Diabetes, and a key contributor within Diabetes Canada.Our experts examine the critical role that primary care plays in the early diagnosis of T2D, personalizing and implementing treatment plans, and facilitating regular screening for...
2025-02-0316 min
Within Range: Demystifying Diabetes Tech for Healthcare ProfessionalsWithin Range: Demystifying Diabetes Tech Interview with Prof. Jean-Pierre RivelineOmnipod® 5 provides impressive quality of life improvements for people living with diabetes (PWD)Recorded at the 60th Annual EASD Scientific Meeting in Madrid, Spain, our host, Cindy Pickering, brings you a conversation with Professor Jean-Pierre Riveline. Prof. Riveline is a senior practitioner in diabetology-endocrinology at Lariboisière hospital as well as a Professor in endocrinology, and the Leader of the Centre Universitaire du Diabète et de ses Complications (CUDC), Lariboisière Hospital in Paris, France. Together Cindy and Prof. Riveline discuss revolutionary AID technology and the impressive impact that Omnipod 5 is making on both gly...
2025-01-2020 min
Diving Into DiabetesNavigating Type 1 Diabetes ScreeningHow is our understanding of autoimmunity in type 1 diabetes (T1D) shifting the way it’s detected and treated?Our host, Dr. Alice Cheng, discusses this topic and more with Dr. Bruce Perkins, Professor, Endocrinologist, Epidemiologist, and Clinician-Scientist in the Faculty of Medicine and the Institute for Health Policy Management and Evaluation at the University of Toronto.In this episode, the stages of T1D development and the role of autoimmunity are summarized, before examining the clinical benefits and challenges of autoantibody testing for the early detection of T1D. Current practices are discussed, as we...
2024-11-2715 min
Diving Into DiabetesThe Roots of Type 1 DiabetesWhat do we know about the developmental stages of type 1 diabetes (T1D), and how can this understanding ultimately lead to improved patient outcomes?Our host, Dr. Alice Cheng, explores these questions with Dr. Bruce Perkins, Professor, Endocrinologist, Epidemiologist, and Clinician-Scientist in the Faculty of Medicine and the Institute for Health Policy Management and Evaluation at the University of Toronto.Our experts kick off the discussion by identifying the key differentiators between type 1 and type 2 diabetes, before diving into the presence and involvement of autoantibodies in the development of T1D. Dr. Perkins details the...
2024-11-2711 min
Within Range: Demystifying Diabetes Tech for Healthcare ProfessionalsThe Simplicity of Omnipod® 5 allows a wider range of people with diabetes to try Automated Insulin Delivery (AID)Recorded at the 60th Annual EASD Scientific Meeting in Madrid, Spain, our host, Cindy Pickering, brings you a conversation with Dr. Jackie Elliott. Dr. Elliott is the clinical lead for diabetes at Sheffield Teaching Hospitals in the United Kingdom. Together Cindy and Dr. Elliott discuss revolutionary AID technology and how the simplicity of Omnipod 5 is changing clinical practice. Dr. Elliott describes some impactful case examples of how Omnipod 5 has improved outcomes for not only the person living with diabetes but has also given freedom back to the whole family. Some references to the Insulet Sponsored Symposium at EASD are made...
2024-11-2739 min
Vanguards of Healthcare by Bloomberg IntelligenceInsulet Sees Long Ramp Treating Type 2 Diabetes with Omnipod 5Insulet’s Omnipod 5 automated insulin delivery (AID) system has avenues to expand as it’s revolutionized the way patients treat their diabetes, including the new indication for Type 2 diabetes, CEO Jim Hollingshead explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Hollingshead sits down with BI analyst Matt Henriksson for an in-depth interview on Insulet’s Omnipod patch pump technology, how on-the-body wear compares to traditional insulin pumps and opens access to patients still using syringes, and expansion opportunities with Omnipod 5 in international markets and with the Type 2 diabetic cohort in the US.Find this and other...
2024-11-1452 min
Closing BellClosing Bell Overtime: IAC CEO On Potentially Spinning Off Angi and M&A Opportunities; Insulet CEO On Strong Pump Demand and Expanding In The Type 2 Diabetes Market 11/11/24The Dow closed above 44,000 and the S&P 500 closed above 6,000 for the first time as stocks extend their bullish run since the election. Bespoke’s Paul Hickey and Envestnet’s Dana D’Auria break down what could be ahead through year-end. Apollo Global’s Torsten Slok on the Fed’s next move. Insulet CEO Jim Hollingshead on the company seeing strong demand for its insulin pump. IAC CEO Joey Levin on the company’s decision to explore spinning off its ownership in Angi—and what he might do with the cash.
2024-11-1143 min
Diabetes Connections | Type 1 DiabetesIn the News... Omnipod 5 iPhone update, Libre & Dexcom news, overnight insulin pump and more!It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: iPhone control for Omnipod 5 rolls out, Libre is approved for use in CT scans and MRIs, Dexcom files for 15 day wear, Luna nighttime pump goes to trial, iLet cell trials move forward and more! Find out more about Moms' Night Out Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) O...
2024-11-0107 min
Diabetes Connections Type 2In the News... Omnipod 5 iPhone update, Libre & Dexcom news, overnight insulin pump and more!It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: iPhone control for Omnipod 5 rolls out, Libre is approved for use in CT scans and MRIs, Dexcom files for 15 day wear, Luna nighttime pump goes to trial, iLet cell trials move forward and more! Find out more about Moms' Night Out Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod...
2024-11-0107 min
Beyond the BolusMind Over Diabetes: A Psychologist’s Take on the Freedom of Omnipod® 5 for iPhone (featuring Mark Heyman, PhD CDCES)The guest on this episode has an ongoing commercial relationship with Insulet, and Insulet has paid a fee for their participation in this podcast. In this Beyond the Bolus episode, Mark Heyman, PhD CDCES, shares his experience using the Omnipod 5 App for iPhone as part of the limited market release (LMR). Dr. Heyman discusses this system's new features and how these have benefited his mental well-being and reduced his diabetes distress. Dive in to hear how the Omnipod 5 App for iPhone could help enhance your patient's diabetes management!
2024-10-2938 min
Beyond the BolusOptimizing Omnipod® 5 for Better Patient Outcomes (featuring Jennifer Okemah MS, RDN, CSSD, BC-ADM, CDCES)The guest on this episode has an ongoing commercial relationship with Insulet, and Insulet has paid a fee for their participation in this podcast.Recorded Live at ADCES in New Orleans, Louisiana. In this episode, Jennifer Okemah joins us as we dive deep into SmartAdjust™ technology, the groundbreaking algorithm behind the Omnipod 5 Automated Insulin Delivery System. Jennifer breaks down how healthcare providers can fine-tune this innovative tool to better support patients with diabetes, ensuring more personalized insulin delivery to meet your patients’ individual needs. Discover actionable strategies to maximize the benefits of SmartAdjust™ technology, improve patient results, and en...
2024-10-2330 min
Community CornerInsulet Corporation Behavior - Episode #911Welcome back to the Community Corner podcast! Today we're exploring the behavioral finance logic of Insulet Corporation! Don't forget to subscribe and leave a like to stay tuned for future episodes! Follow us on Instagram - @communitycorner_podcast Timecodes: 0:15 - Introduction 2:15 - Early Breakthroughs 4:01 - Insulet Corporation’s Role in the Future
2024-10-1008 min
Community CornerInsulet Corporation - Episode #422Welcome back to the Community Corner podcast! Today we're exploring the story of Insulet Corporation! Don't forget to subscribe and leave a like to stay tuned for future episodes! Follow us on Instagram - @communitycorner_podcast Timecodes: 0:15 - Introduction 2:15 - Early Breakthroughs 4:01 - Insulet Corporation's Role in the Future
2024-10-0906 min
Diabetes Connections Type 2Omnipod 5 Brings Automated Insulin Delivery to Type 2 DiabetesAutomated insulin delivery has been an incredible advancement for insulin pumps. Now, for the first time, the FDA has approved a system for people with type 2. It’s called Omnipod 5. We’re going to talk about how it works, who it helps, and what the company found in their studies of people who use it. My guest this week is Dr. Trang Ly, truly one of the pioneers of studying and innovating around automated insulin delivery – or AID – systems. She is the Medical Director at Insulet, the company that makes Omnipod. Prior to joining Insulet, Dr. Ly served as...
2024-09-2528 min
Beyond the BolusUnlock the Future of Type 2 Diabetes Care with Dr. Viral ShahRecorded Live at ADCES in New Orleans, Louisiana.Dive into the groundbreaking SECURE T2D study, the largest and most diverse trial ever conducted on Automated Insulin Delivery (AID) for people with type 2 diabetes.Discover how Omnipod 5 demonstrated improvements in A1C levels, increased time in range (TIR), and participant-reported reduction in Diabetes Distress. Dr. Viral Shah from the Indiana University School of Medicine, and an investigator in this trial, reveals key insights on how Omnipod 5 can help simplify diabetes management.Don’t miss th...
2024-09-1116 min
Within Range: Demystifying Diabetes Tech for Healthcare ProfessionalsAID systems are revolutionizing paediatric diabetes careRecorded at the ADA 84th Scientific Sessions in Orlando, Florida, host Kate Neal brings you a conversation with Cari Berget. Cari is a leading expert in diabetes and technology as a Pediatric Nurse and diabetes educator from the Barbara Davis Center in Denver, Colorado. Together Kate and Cari discuss revolutionary AID technology and the impact on pediatric patient outcomes. Cari highlights initiation and implementation strategies she uses to manage nearly 1,000 pediatric patients on Omnipod 5 and other AID systems. Cari introduces the audience to the PANTHER® Program and describes the development and use of the PANTHERTOOL®, a resource to help HCPs...
2024-09-0438 min
Beyond the BolusThe Power of the PodRecorded live at the ADA Conference in Orlando, Florida.Dive into the future of diabetes management with Eric Benjamin, Insulet’s Chief Product & Customer Experience Officer. In this episode, Eric reveals the innovative journey behind Omnipod, highlighting our relentless focus on customer needs and top-tier performance with every Pod change. Discover how we're revolutionizing Automated Insulin Delivery with our wearable, tubeless Pod, and learn how these advancements simplify life for people with diabetes. Don't miss this insider's perspective on transforming care through cutting-edge technology....
2024-08-2716 min
Beyond the BolusOmnipod 5 with Dexcom G7 Integration is Here!Recorded live at the ADA Conference in Orlando, Florida. Nancy Hanna is joined by Dr. Pablo Mora who is an Endocrinologist at the North Texas Diabetes & Endocrinology Medical Center in Plano, Texas. During this episode, Nancy and Dr. Mora discuss the integration between the Omnipod 5 Automated Insulin Delivery System and the Dexcom G7 CGM. Dr. Mora discusses his experience as part of the Limited Market Release for Omnipod 5 with Dexcom G7 and provides insights into the benefit of this integration for his patients with type 1 diabetes. Listen to learn how Dr. Mora has...
2024-08-1900 min
Beyond the BolusChallenging AID Candidacy NormsRecorded live at the ADA Conference in Orlando, Florida 2024.Nancy Hanna is joined by Cari Berget MPH, RN, CDCES who is a Research Instructor of Pediatric Endocrinology at the University of Colorado School of Medicine – Barbara Davis Center. During this episode, Nancy and Cari discuss automated insulin delivery (AID) candidacy and challenge the perception that people need to meet certain requirements to be considered for AID. Cari shares her experience prescribing diabetes technology to patients who typically might not been considered for automated insulin delivery and shows the progress and clinical benefits that some of he...
2024-08-1900 min
Beyond the BolusOmnipod 5 Real-World Evidence Data: A Deep DiveRecorded live at the ADA Conference in Orlando, Florida.Nancy Hanna is joined by Dr. Greg Forlenza who is an Endocrinologist at the University of Colorado School of Medicine – Barbara Davis Center. Dr. Forlenza is the lead author of a publication in the Diabetes Technology & Therapeutics in which the use of the Omnipod 5 Automated Insulin Delivery System was analyzed in almost 70,000 people with type 1 diabetes.Nancy and Dr. Forlenza discuss the relevance of real-world evidence from a diverse group of patients and how that translates into actual practice. Learn ho...
2024-08-1900 min
DeviceTalks Podcast NetworkHow can the cloud and connected devices improve patient care? Insulet CEO Jim Hollingshead knowsIn this episode of DeviceTalks Weekly Podcast, Host Tom Salemi interviews Jim Hollingshead, PhD, the CEO of Insulet. Hollingshead had the unenviable job of taking over for CEO Shacey Petrovic when she left the insulin-delivery company two years ago. Hollingshead previously had helped ResMed develop its industry-leading connectivity/cloud strategy. In this conversation you’ll hear about his journey and what steps Insulet has taken to build share in the Type 1 and Type 2 diabetes markets
MassDevice Editor Chris Newmaker returns with his newsmakers - Asensus Surgical, Tandem, Stryker, Perceptive, and BiVacor.
This episode is sponsored by DeviceTalks West. Register to at...
2024-08-021h 16DeviceTalks Podcast NetworkHow can the cloud and connected devices improve patient care? Insulet CEO Jim Hollingshead knowsIn this episode of DeviceTalks Weekly Podcast, Host Tom Salemi interviews Jim Hollingshead, PhD, the CEO of Insulet. Hollingshead had the unenviable job of taking over for CEO Shacey Petrovic when she left the insulin-delivery company two years ago. Hollingshead previously had helped ResMed develop its industry-leading connectivity/cloud strategy. In this conversation you’ll hear about his journey and what steps Insulet has taken to build share in the Type 1 and Type 2 diabetes markets
MassDevice Editor Chris Newmaker returns with his newsmakers - Asensus Surgical, Tandem, Stryker, Perceptive, and BiVacor.
This episode is sponsored by DeviceTalks West. Register to at...
2024-08-021h 16
Within Range: Demystifying Diabetes Tech for Healthcare ProfessionalsHitting the target for successful glycemic management with Omnipod 5 - with Dr. Dorothee DeissDr. Dorothee Deiss joins our podcast hosts Kate and Cindy to explore her work with AID systems. Dr. Deiss is a paediatric endocrinologist from Berlin, working at the DRK Clinic Berlin Westend. She says that \"every person with Type 1 Diabetes should be offered an AID system.\" Find out how you can greatly improve glycaemic control and quality of life for patients with Type 1 Diabetes. Omnipod 5 is easy to use and has an easy-to-understand algorithm that adjusts insulin delivery based on predicted glucose, 60 minutes into the future. As our hosts Kate and Cindy explore with Dr. Deiss, onboarding and follow-up care...
2024-07-2428 min
Le point sur le diabèteSurmonter l’inertie thérapeutique et usage pratique de l’insuline basale en contexte d’intensification du traitement du diabètePourquoi est-il encore important d’instaurer et d’optimiser le traitement par insuline basale en temps opportun dans la prise en charge du diabète, en dépit de l’utilisation croissante d’autres traitements antihyperglycémiants, comme les agonistes du récepteur du peptide-1 apparenté au glucagon (GLP1-RA)?Le Dr Alexandro Zarruk, notre hôte, répondra à la question avec la Dre Chantal Godin, endocrinologue au CIUSSS de l’Estrie-CHUS et à l’Hôtel-Dieu du CHUS et professeure agrégée d’enseignement clinique à l’Université de Sherbrooke.Cet épisode est axé sur les facteurs en cause dans l’ine...
2024-06-1717 min
Within Range: Demystifying Diabetes Tech for Healthcare ProfessionalsUnderstanding Omnipod 5: The future of Diabetes TechIn our inaugural episode, hosts Kate Neal and Cindy Pickering are joined by Dr. Sufyan Hussain, consultant in diabetes, endocrinology and general medicine at Guys and St Thomas’s Hospital in London. Dr. Hussain talks about his personal and professional experience with type 1 diabetes and how he has seen technology rapidly evolve over the past decade. He discusses his work as a clinician, helping others to manage diabetes with game changing results through Omnipod® 5 and the approach to training patients on the Omnipod 5 System in the UK. He provides practical advice to clinicians and sets expectations for patients just starting out...
2024-05-2929 min
Digital ClinicLeveraging Technology and Creating Value in MedTech Digital MarketingHear from Monique Trulson, Senior Director of Global Digital Marketing at Insulet, as she shares her fascinating journey from meteorologist to digital marketing leader in the MedTech industry. Monique discusses the remarkable evolution of digital marketing, the challenges of balancing privacy and the role of compliance with personalization, and the importance of empathy in connecting with audiences. She emphasizes the significance of adapting to change, continuously learning, and finding meaning in one's work.
Monique also highlights the power of leveraging technology to create value and human connections with less data, particularly in the context of MedTech marketing. T...
2024-05-2822 min
Within Range: Demystifying Diabetes Tech for Healthcare ProfessionalsWelcome to Within RangeWithin Range is the new podcast from Insulet. Diabetes tech innovation moves quickly and it can be challenging to keep all the details about the available AID systems straight. Within Range: Demystifying Diabetes Tech will help bust some myths and clear up any confusion about the Omnipod® 5 Automated Insulin Delivery System. Our dynamic co-hosts Cindy Pickering & Kate Neal lead conversations with Healthcare Professionals with varying specialties and backgrounds. From clinical research and guidelines, system details, algorithm functionality, to the more practical aspects of helping people live with T1D, you are invited to listen in, while they cover a variety o...
2024-03-0501 min
Fast Five Medtech News PodcastInsulet integrates Abbott FreeStyle Libre 2 Plus, Omnipod 5Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, February 8, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
ShiraTronics completed its implantable migraine therapy pilot enrollment and set up its U.S. clinical study. Fast Five hosts Danielle Kirsh and Sean Whooley talk about the technology and what some of the data has shown so far.
TAVR and Critical Care drove Edwards to its fourth-quarter sales beat. Hear more ab...
2024-02-0812 minFast Five Medtech News PodcastMedtronic wants to prioritize restoring earnings power; Insulet has a Class I recallWelcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, January 10, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Orthofix appointed a new CFO as Massimo Caliafiore took over as CEO. Fast Five hosts Danielle Kirsh and Sean Whooley discuss who takes on the financial leadership role and some of their career history.
Dexcom has submitted a new glucose sensor to the FDA and expects to launch it this summer. Who...
2024-01-1012 minVanguards of Healthcare by Bloomberg IntelligenceInsulet Leads Insulin-Patch Pump DriveInsulet is disrupting how patients can treat their diabetes, capitalizing on its differentiated Omnipod on-the-body delivery technology, CEO Jim Hollingshead explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Hollingshead sits down with BI analyst Matt Henriksson for an in-depth interview on Insulet’s Omnipod patch pump technology, how on-the-body wear compares with traditional insulin pumps and opens access to patients still using syringes, and upcoming developments to expand its automated insulin-delivery technology to Type 2 diabetic patients.See omnystudio.com/listener for privacy information.
2024-01-0547 minFast Five Medtech News PodcastFormer Stimwave CEO defrauded investors out of $41M; Philips recalls MRI system due to explosionsWelcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, December 22, 2023.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Insulet has applauded guidance from NICE on hybrid closed loop insulin delivery systems. Fast Five hosts Sean Whooley and Danielle Kirsh talk about what the guidance recommended and why it is important for Insulet.
J&J's Acclarent won an FDA nod for its pediatric ear tube balloon dilation system ahead of it...
2023-12-2210 min
Earnings SeasonInsulet Corporation, Q3 2023 Earnings Call, Nov 02, 2023Insulet Corporation, Q3 2023 Earnings Call, Nov 02, 2023
2023-12-061h 08
Beyond the BolusDiabetes Distress with Dr. William PolonskyRecorded live at the ADCES Conference in Houston, Nancy Hanna and Dena Gottesman are joined by Dr. William Polonsky. Dr. Polonsky is the founder and president of the Behavioral Diabetes Institute, an organization dedicated to studying the unmet psychological needs of people living with diabetes. He’s also an Associate Clinical Professor at the University of California in San Diego. Highlights include:• Where to find the best lactose-free ice cream in the universe!• Dr. Polonsky’s golden nugget for new diabetes educators. • The one question you should ask all your patients at every visit. • How the world’s...
2023-11-0600 min
Beyond the BolusCelebrating 50 years of Advancing Diabetes Care & EducationThis special episode is a compilation of conversations from the Association of Diabetes Care & Education Specialists (ADCES) 2023 conference in Houston. Joining Nancy on day 2 of the conference were a few very special guests. Alissa Heizler-Mendoza, a registered dietitian and certified diabetes care and education specialist dropped by the studio to discuss her role of leading the advocacy and government affairs team at Insulet. She empowers us to elevate our voices to influence change and help more people living with diabetes access life-changing technology.Sarah Yourman-Tota also stopped by to chat with Nancy about her work in p...
2023-10-0900 min
Le point sur le diabèteBoucler la boucle dans la prise en charge du diabète de type 1De nombreux problèmes affligent les personnes atteintes de diabète de type 1 tout au long de leur parcours avec la maladie. Comment peut-on utiliser les nouvelles approches novatrices de prise en charge du diabète afin de les aider à surmonter ces défis?Notre hôte, la Dre Chantal Godin, examine plus en détail ce sujet avec la Dre Marie-Andrée Corbeil, endocrinologue et chef de service au CISSS de la Montérégie-Centre au Centre hospitalier du Haut-Richelieu, et professeure à l’Université de Montréal et à l’Université de Sherbrooke.Nous aborderons dans cet épisode le...
2023-08-1517 min
Diving Into DiabetesClosing the Loop in the Management of Type 1 Diabetes Numerous challenges afflict patients with type 1 diabetes (T1D) throughout their disease journey. How can newer, more innovative management approaches help patients overcome these challenges?This episode discusses the challenges that regularly burden patients with T1D, and how recent technological breakthroughs, such as automated insulin pumps and continuous glucose monitoring (CGM), have been transformative in diabetes management.Our host, Dr. Ronald Goldenberg, takes a deeper look into this topic with Dr. Bruce Perkins, Professor, Endocrinologist, Epidemiologist, and Clinician Scientist in the Faculty of Medicine and the Institute for Health Policy Management and Evaluation at...
2023-08-1518 minFast Five Medtech News PodcastShockwave Medical to raise $500M, ZimVie has an updated spin implant set to launch this fallIn this episode, Fast Five hosts Sean Whooley and Danielle Kirsh break down some of the second-quarter highlights for Insulet as it continues to report impressive revenue growth. The automated insulin delivery technology developer offered even more optimism for the rest of the year, raising its guidance as sales of the Omnipod system are taking off. There's also promising news on the product side as Insulet recently shared an update on the progress of the Omnipod's integration with a popular continuous glucose monitor.
Meanwhile, Imperative Care has a new organizational structure, breaking up its business arms into four siloed operating...
2023-08-1009 min
Beyond the BolusA Dynamic Duo: Omnipod & DexcomJoin us for an insightful journey into the world of diabetes management technology on this very special episode of Beyond The Bolus. Recorded live from the American Diabetes Association’s 83rd Scientific Sessions in San Diego, host Nancy Hanna is joined by Dexcom’s Cher Pastore in our very first simulcast. To explore how Omnipod and Dexcom are influencing the dynamics of diabetes technology and reshaping patient outcomes for the better, they’re joined by Dr. Viral Shah - an endocrinologist whose research into these innovative therapies has touched and improved countless lives. During the episode, you'll discover how technological advanceme...
2023-08-1000 min
Beyond the BolusTeenage TransitionsInsulet and Beyond The Bolus are back at the ADA Scientific Sessions. Nancy Hanna, Clinical Services Manager at Insulet, is joined by Dr. Anita Swamy for a special live podcast, recording at the Omnipod booth in San Diego. Join them on a truly enlightening journey into the world of diabetes management as seen through the lens of the latest technology. The Omnipod 5 system offers an optimistic approach towards alleviating the daily challenges associated with managing diabetes. Dr. Swamy is a stalwart in diabetes management, and she delivers a masterclass for the listeners on integrating technology into pat...
2023-08-1000 min
Motivated to Lead Podcast - Mark KlingsheimBrittany Bradrick, COO & CFO, Board MemberThis week we revisit our conversation with Brittany Bradrick. Brittany has over 20 years of experience in finance, strategy, and corporate development for life science companies, with operational and advisory experience. Brittany is a COO & CFO at Neurelis, Inc. Before that; she was the COO and CFO at ViaCyte. Previously she was Vice President, Strategy and Corporate Development at Insulet Corporation, an insulin pump company. Before Insulet, she was Director, Business Development and Alliance Management at Abbott Diabetes Care, a glucose measurement company. Before Abbott, Brittany was an investment banker in the life science industry for ten years at Piper...
2023-06-2916 min
FundCalibre - Investing on the go263. Why investment meetings are an art, not a scienceAnjli Shah, manager of the abrdn SICAV I Global Mid-Cap Equity fund, demonstrates the effectiveness of the fund’s ability to run small-cap winners and buy future large-caps early. Anjli acknowledges the challenges faced in 2022, due to a combination of style rotation in global markets and mid-cap growth being affected by higher inflation and interest rate expectations. This episode also focuses on three holdings: Cadence, a US company specialising in computational software for semiconductor design, Moncler, an Italian luxury brand known for its outerwear, and small-cap graduate, Insulet, a US manufacturer of tubeless insulin pumps. Anjli explains th...
2023-06-2916 minEarnings SeasonInsulet Corporation Q1 2023 Earnings Call May 04 2023Insulet Corporation Q1 2023 Earnings Call May 04 2023
2023-05-301h 09
Fortune 1000 by Kaptain TiFortune 1000 :: Ep. 19 - Insulet :: 847Fortune 1000 :: Ep. 19 - Insulet :: 847
2023-03-1844 minEarnings SeasonInsulet Corporation, Q4 2022 Earnings Call, Feb 23, 2023Insulet Corporation, Q4 2022 Earnings Call, Feb 23, 2023
2023-03-011h 07
Pharmacy Podcast NetworkOmnipod Innovation Story- From Concept to Future State | Omnipod Simplify LifeWe are excited today to bring you a special guest. Jason O’Connor is
the Vice President of Product at Insulet Corp., makers of Omnipod. In his
role, Jason oversees the development of the innovation pipeline at Insulet.
We have no doubt that you, our audience will find this interview to be very
engaging and insightful on the innovation story of Omnipod
The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM/Controller is not waterproof. The Dexcom G6 Sensor and transmitter are water-resistant and may be subme...
2023-02-2021 min
Diabetes Connections | Type 1 DiabetesIn the News... Dexcom G7 launch, cannabis and type 1, Insulet acquisitions and more!It's In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: Dexcom G7 is now available in the United States, Insulet buys assets from Bigfoot and another California company, new studies about cannabis and type 1 and COVID and diabetes, different predictors of type 2 in women and men, plus scholarships for T1D students. Please visit our Sponsors & Partners - they help make the show possible! Take Control with Afrezza Omnipod - Simplify Life Learn about Dexcom Check out...
2023-02-1707 min
Diabetes Connections | Type 1 DiabetesIn the News... Dexcom G7 Release Date, Omnipod Eros Discontinued, Best Age to Screen for T1D and more!It's In the News, a look at the top stories and headlines from the diabetes community happening now. This week, Dexcom sets a US release date for the G7, we find out whether Tandem will be a Tidepool Loop partner now that Insulet and Medtronic are out, Omnipod Eros to be discontinued, a new study says there's a better age to test kids for type 1, a new smart insulin pen sensor can also be used to track dosing of GLP-1 medications, a new twist in the Faustman study of the TB vaccine to treat diabetes, the Sims 4 update brings...
2023-02-0308 min
Diving Into DiabetesTitration Investigation: Basal Insulin and Fixed-Ratio Combination Protocols Titration is a crucial element for individuals with diabetes taking basal insulin to achieve their glycemic targets, so how do we ensure we’re doing it optimally?Our host, Dr. Ronald Goldberg, takes a deeper look into this topic with Dr. Irene Hramiak, a Professor of Medicine at Western University, and the current Department of Medicine Site Chief and Endocrinologist at St. Joseph’s Hospital.This episode discusses the history of basal insulin titration and how standard protocols have changed over time, with new advances brought on by clinical evidence from trials like the INSIGHT study, and...
2023-02-0113 min
Diabetes Connections | Type 1 DiabetesIn the News... More T2D predicted, Basal-only pump planned, Glucagon discontinued.. and more!It's In the News, a look at the top stories from the diabetes community from the last seven days. This week: predictions of a huge increases in cases of type 2, insulin prices are capped for those with Medicare, Omnipod commits to a basal-only pump for people with type 2, and more! In the news is brought to you by Athletic Greens! Find out more: https://athleticgreens.com/stacey Check out Stacey's books! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here Episode Transcription Below (or coming soon!)
2023-01-0606 min
Beyond the BolusOmnipod® 5 Automated Insulin Delivery System: Facts vs. Fake News Part 2Nancy Hanna RN, BSN, CDCES and Dena Gottesman MS, RD, CDCES are joined by Leslie Barrett MS, RD, CDCES to clear up common misconceptions about the Omnipod® 5 Automated Insulin Delivery System. Leslie has been working on Omnipod® 5 since the development from user experience and design to clinical trial site training and support. In part 2 of this fact from fake news episode she will share more details on the Omnipod 5 algorithm known as SmartAdjust™ technology and best practices for everyday use and optimization. Questions covered in this episode:• What are the requirements for entering Automated Mode?• What are...
2022-12-1500 min
Beyond the BolusOmnipod® 5 Automated Insulin Delivery System: Facts vs. Fake News Part 1Nancy Hanna RN, BSN, CDCES and Dena Gottesman MS, RD, CDCES are joined by Leslie Barrett MS, RD, CDCES to clear up common misconceptions about the Omnipod® 5 Automated Insulin Delivery System. Leslie has been working on Omnipod® 5 since the development from user experience and design to clinical trial site training and support. In this episode she will separate the facts from the fake news, share details on the Omnipod 5 algorithm known as SmartAdjust™ technology and best practices for everyday use and optimization. Questions covered in this episode:• How does the adaptivity of the system work?• What are...
2022-12-1500 min
Diving Into DiabetesExploring Second-Generation Basal Insulin Analogues Do second-generation basal insulin analogues really offer any advantages over their first-generation counterparts? Our host, Dr. Ronald Goldenberg, takes a deeper look into this topic with Dr. Alice Cheng, an endocrinologist at Credit Valley Hospital in Mississauga and St. Michael's Hospital in Toronto. She is also an Associate Professor in the Department of Medicine at the University of Toronto and the current the Chair of the Professional Section of Diabetes Canada and an Associate Editor for the Canadian Journal of Diabetes. This episode focuses on second-generation basal insulin analogues, and the clinical benefits they confer compared to pr...
2022-11-1513 minEarnings SeasonInsulet Corporation, Q3 2022 Earnings Call, Nov 03, 2022Insulet Corporation, Q3 2022 Earnings Call, Nov 03, 2022
2022-11-041h 04
Diving Into DiabetesExamining Diabetes and Renal Impairment Did you know that people with type 2 diabetes having chronic kidney disease are at an increased risk of hypoglycemia?Our host, Dr. Ronald Goldenberg, takes a deeper look into this topic with Dr. Alice Cheng, an Endocrinologist at Credit Valley Hospital in Mississauga, and St. Michael's Hospital in Toronto. She is also an Associate Professor in the Department of Medicine at the University of Toronto and the current the Chair of the Professional Section of Diabetes Canada and Associate Editor for the Canadian Journal of Diabetes.This episode discusses best practices on how to manage type 2...
2022-10-1510 min
Diabetes Connections | Type 1 DiabetesIn the News.. Medtronic safety alert, Omnipod 5 in Europe, T1D Index launched and more!It's In the News! This week's top diabetes headlines and stories include: cybersecurity risk cited for some Medtronic pumps, Omnipod 5 gets European approval, new data about the Freestyle Libre and avoiding hospitalizations, the new T1D Index and more! Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the show possible! *Click here to learn more about OMNIPOD* *Click here to...
2022-09-2306 min
Le point sur le diabèteUne étude très attendue : InRange : Comparaison entre l’insuline glargine à 300 U/mL et l’insuline dégludec à 100 U/mL dans le diabète de type 1Les mesures de la surveillance du glucose en continu s’imposent comme des paramètres clés pour la prise en charge du diabète, mais comment les appliquer en pratique clinique, notamment pour les personnes diabétiques sous insuline basale?Notre hôte, la Dre Chantal Godin, endocrinologue au CHUS du CIUSSS de l’Estrie et professeure à l’Université de Sherbrooke et à l’Université de Montréal, décortique la question.On dispose de peu de données sur l’utilité de la surveillance du glucose en continu pour mesurer les résultats dans la pratique clinique et...
2022-09-0822 min
Diabetes Connections | Type 1 DiabetesOmnipod 5: Answering your questions aboutOmnipod 5 was approved earlier this year and just rolled out to a wider release. So how is the first tubeless automated insulin delivery system doing in the real world? We put together a panel of early adopters and got their feedback. That was great, but it brought up quite a few questions, so we reached out to Omnipod for clarification and follow up. The result is a super-sized episode full of info! Our panel: Liat Kochavi, mother an almost-8-year-old with T1D, Stephanie Williams, mother of a teen with type 1, and Sam Durante who was diagnosed...
2022-09-061h 07
Beyond the BolusWill Bolus for Beignets Part 2: Candid Conversations from ADASynopsis: In the second part of this episode, Nancy and Dena continue with impromptu interviews of attendees at the 82nd ADA conference. These talks include topics such as the accessibility of new diabetes treatment technology with Dr. Osama Hamdy, helping patients achieve their diabetes goals with individualized care with Jeremy Beaulieu, glucose testing practices with Clinical Professor in Medicine Dr. Edward Chao, as well as a conversation with this year’s Outstanding Physician Clinician in Diabetes Award winner, Dr. Janet McGill. Guest Bios: Dr. Osama Hamdy, MD, is one of the world’s though...
2022-08-2200 min
Beyond the BolusWill Bolus for Beignets Part 1: Candid Conversations from ADASynopsis: In this episode, Nancy and Dena commence the first part of a compilation of interviews conducted at the 82nd ADA conference. These talks include topics such as exercise with closed-loop therapy with Dr. Laurel Messer, reducing stigma surrounding diabetes with Nicole Patience, and a conversation with this year’s Outstanding Educator in Diabetes Award winner, Dr. Amy-Hess Fischl. Guest Bios: Dr. Laurel Messer, PhD, RN, CDCES is a Clinical Nurse Scientist and Assistant Professor at the Barbara Davis Center for Childhood Diabetes, University of Colorado. She is a research investigator in the ped...
2022-08-2200 min
Beyond the BolusBuilding Your Diabetes Dream TeamInsulet has paid the guest speakers of this podcast, Dr. Gregory Forlenza and Dr. Diana Isaacs, a fee to participate in this podcast. Dr. Gregory Forlenza and Dr. Diana Isaacs have an ongoing commercial relationship with Insulet and receive financial compensation for this relationship. Synopsis: In the second episode of Beyond the Bolus, Nancy and Dena examine the importance of the diabetes care team as they walk a day-in-the-life with Dr. Gregory Forlenza and Dr. Diana Isaacs. Over the episode, these experts discuss the value of a team approach within their practices, the benefits of sha...
2022-08-2200 min
Beyond the BolusThe Future is Bright - Clinical Data and New TechnologyInsulet has paid the guest speakers of this podcast, Dr. Grazia Aleppo and Dr. Amy Criego, a fee to participate in the making of this podcast. Dr. Grazia Aleppo and Dr. Amy Criego have an ongoing commercial relationship with Insulet and receive financial compensation for this relationship. Synopsis: In the inaugural episode of Beyond the Bolus, recorded live from the 82nd American Diabetes Association Conference, Nancy and Dena meet with Endocrinologists Dr. Grazia Aleppo and Dr. Amy Criego to discuss ADA highlights and understand how technology advancements are translating into day-to-day wins for people with diabetes.
2022-08-2200 minEarnings SeasonInsulet Corporation, Q2 2022 Earnings Call, Aug 04, 2022Insulet Corporation, Q2 2022 Earnings Call, Aug 04, 2022
2022-08-0859 min
Diabetes Connections | Type 1 DiabetesIn the News... Libre 3 approved, Dexcom addresses Insulet talk, Ozempic TikTok trend and more!Got a few minutes? Get caught up on the top diabetes stories and headlines of the past week. The FDA approves Abbott's Freestyle Libre, Dexcom addresses reports it may buy Insulet, Ozempic becomes a TikTok trend, Diabetes Scholarships for college and more! Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! ----- Episode...
2022-06-0307 min
Beyond the BolusWelcome to Beyond The BolusFind out more about what you can expect from this debut podcast series from Insulet including the first episodes recorded live at ADA in New Orleans in June.
2022-05-3100 min
Diabetes Connections | Type 1 DiabetesIn the News... Dexcom to acquire Omnipod? People with T1D living longer, JDRF awareness on Everest and more!It's in the news! Got a few minutes? Get caught up! Top stories this week: Dexcom is reportedly in talks to buy Omnipod, Abbott & Dexcom sue and countersue each other over patents, new study showing people with type 1 diabetes are living longer, a JDRF advocate climbs Mt Everest, and more! Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes...
2022-05-2705 min
Diabetes Connections | Type 1 DiabetesOmnipod 5 gets FDA Approval - Insulet's Medical Director Answers Your QuestionsThe US FDA has approved Insulet's Omnipod 5 Automated Insulin Delivery System. This system was submitted more than a year ago but has been delayed due to COVID 19. Stacey talks to Dr. Trang Ly, Senior Vice President & Medical Director at Insulet Corporation who explains what makes this system different from the other AID systems on the market, what phone control means, what the roll out will look like, insurance issues, Medicare and more. Omnipod 5 FAQs from Insulet DiabetesMine's write up of Omnipod 5 This podcast is not intended as medical advice. If you have those...
2022-02-0147 min
Diabetes Connections | Type 1 DiabetesIn the News... Tandem's tiny pump, more stem cell progress, a new Rufus the Bear & more!Our top stories In the News this week... Tandem Diabetes shares a big R&D update, laying out their product pipeline for the next 5 years. More stem cell progress, this time from Viactye, a look at another non-invasive CGM claim, big news for Rufus the Bear from JDRF and Stacey spends some time remembering Beyond Type 1 CEO Thom Scher. -- Join us LIVE every Wednesday at 4:30pm EST Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use...
2021-12-1008 min
Diabetes Connections | Type 1 DiabetesIn the News.. Tandem & Omnipod updates, T1D kids & COVID and more!It's "In the News..." the only diabetes newscast. This week we find out about: SGLT2 inhibitors, more evidence this T2D med works for T1D, Tandem & Insulet earning calls: what you need to know, Which kids with T1D did even better during COVID? How you sleep could increase risk of gestational diabetes, what's going on for Diabetes Awareness Month and lots more! Have 5 minutes? Give it a listen! -- Join us LIVE every Wednesday at 4:30pm EDT Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign...
2021-11-1206 min
Diabetes Connections | Type 1 Diabetes"We really listened to what people wanted" - A look at Omnipod 5 with HorizonAnticipation just keeps growing for the new Omnipod system, still waiting for FDA approval. This week, we talk to Dr. Trang Ly, Senior Vice President & Medical Director at Insulet Corporation. We'll get an in-depth run through of the features of Omnipod 5 with Horizon, what makes it different from the other hybrid closed loops already on the market, and many other questions you all had. Our previous interview with Insulet CEO Shacey Petrovic This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. ...
2021-08-0345 min
The Med-Tech Talent LabDave Nazzaro- Sr Director of Hardware Engineering and Advanced Technologies- Insulet. Interviewing and hiring in technical functional areasI was joined by Dave Nazzaro, the Sr Director of Hardware Engineering and Advanced Technologies at Insulet Corporation.Dave holds his Bachelor’s of Science degree in Mechanical Engineering from the University of Massachusetts at Lowell and for the last 17 years he has progressively risen through the ranks having worked for a variety of organizations including Fluident, Apple and of course Insulet.Dave was actually on the product design engineering team that was responsible for the development and launch of the first generation Apple watch. For those of you unfamiliar with Insulet Corporation, it is an...
2021-07-2738 min
The Wacky World of DiabetesBringing Innovation to the Market with Tubeless Omnipod Technology with Shacey PetrovicThere is new, winning technology coming to the market that is easier to use than a smartphone, adaptive, completely wireless, and fully controllable by users. Shacey Petrovic is the CEO of Insulet, an innovative medical device company making the lives of people with diabetes easier through the use of its Omnipod product platform. Shacey has a strong background in med tech and life sciences, but also takes the diabetes market by storm with her skills in commercial leadership, sales, marketing, and 'put the patient first' mentality.An incredible individual, I can’t wait for us to dive in...
2021-06-1629 min
Diabetes Connections | Type 1 DiabetesIn the News: Once a week insulin, bolus by phone, and more...It's "In the News..." the only LIVE diabetes newscast! In six minutes, we'll get you up to date on these stories and more: A weekly basal insulin moves forward in trials Bolus by phone comes to one pump system Big study shows how people managed diabetes during COVID Saliva test for glucose in trials Watch the video: https://youtu.be/X0JMDubA1c0 Join us LIVE on Facebook every Wednesday at 4:30pm EDT Sources & links in the transcript below Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group!
2021-05-2006 min
DeviceTalks Podcast NetworkCEO Shacey Petrovic shares how Insulet is convincing people with diabetes to swap shots for `PodsShacey Petrovic, CEO and president of Insulet, explains how the company is giving people with diabetes new tools to manage their disease, a never-ending task that can require HUNDREDS of decisions per day.
In this interview, Petrovic explains why research wasn't for her; why she decided to leave her first CEO job to join Insulet; and how the company is building the a glucose-delivery device that could convince people with diabetes to give up the certainty of the shot.
In this episode, we also hear from Dr. Niki Panich, a practicing physician who is now CEO of a company that...
2021-03-1356 min